Renin-Angiotensin System Inhibitors and Major Cardiovascular Events after Sepsis.
Federico AngrimanLaura C RosellaPatrick R LawlerDennis T KoClaudio M MartinHannah WunschDamon C ScalesPublished in: Annals of the American Thoracic Society (2022)
A new RASi prescription is associated with a reduction in major cardiovascular events after sepsis. A randomized controlled trial should be considered to confirm this finding.